Melodiol Global Health Management
Management criteria checks 2/4
Melodiol Global Health's CEO is Will Lay, appointed in Jan 2022, has a tenure of 2.08 years. total yearly compensation is A$408.50K, comprised of 95.2% salary and 4.8% bonuses, including company stock and options. directly owns 0.81% of the company’s shares, worth A$27.62K. The average tenure of the management team and the board of directors is 2.3 years and 2.1 years respectively.
Key information
Will Lay
Chief executive officer
AU$408.5k
Total compensation
| CEO salary percentage | 95.2% |
| CEO tenure | 2.1yrs |
| CEO ownership | 0.8% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -AU$54m |
| Mar 31 2023 | n/a | n/a | -AU$43m |
| Dec 31 2022 | AU$408k | AU$389k | -AU$33m |
Compensation vs Market: Will's total compensation ($USD266.75K) is about average for companies of similar size in the Australian market ($USD290.73K).
Compensation vs Earnings: Insufficient data to compare Will's compensation with company performance.
CEO
Will Lay
2.1yrs
Tenure
AU$408,495
Compensation
Mr. William Lay, also known as Will, B.Com (Hons.) serves as Group Chief Executive Officer, Managing Director and Director at Melodiol Global Health Limited (formerly known as Creso Pharma Limited) since J...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Non-Executive Chairman | 8.3yrs | AU$120.00k | 0.038% A$ 1.3k | |
| Group CEO | 2.1yrs | AU$408.50k | 0.81% A$ 27.6k | |
| Chief Financial Officer | 6.3yrs | AU$314.43k | 0.018% A$ 610.9 | |
| Executive Director | 2.1yrs | AU$193.01k | 0.059% A$ 2.0k | |
| Executive Director | 2yrs | AU$88.19k | 5.09% A$ 173.8k | |
| Commercial & Marketing Director | 5.1yrs | no data | no data | |
| Managing Director of Halucenex | no data | no data | no data | |
| Managing Director of Impactive | no data | no data | no data | |
| Joint Company Secretary | 5.3yrs | no data | no data | |
| Strategic Consultant & Chair of Scientific Advisory Committee | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
Experienced Management: ME1DA's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Non-Executive Chairman | 8.3yrs | AU$120.00k | 0.038% A$ 1.3k | |
| Group CEO | 2.1yrs | AU$408.50k | 0.81% A$ 27.6k | |
| Executive Director | 2.1yrs | AU$193.01k | 0.059% A$ 2.0k | |
| Executive Director | 1.3yrs | AU$88.19k | 5.09% A$ 173.8k | |
| Strategic Consultant & Chair of Scientific Advisory Committee | 2.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.1yrs | no data | no data | |
| Independent Non-Executive Director | 2.1yrs | AU$93.50k | 0.25% A$ 8.5k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 6.9yrs | no data | no data | |
| Non-Executive Director | 1.3yrs | AU$6.97k | no data | |
| Non-Executive Director | 1.3yrs | AU$18.41k | no data |
2.1yrs
Average Tenure
72.5yo
Average Age
Experienced Board: ME1DA's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.